SCHEMBL24049700

SCHEMBL24049700

B[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.52
CTSB P07858 2/20 0.52
KLK5 Q9Y337 1/20 0.52
SYK P43405 1/20 0.50
CTSS P25774 3/20 0.47
PPARA Q07869 1/20 0.47
IL1RN P18510 1/20 0.46
ERAP2 Q6P179 1/20 0.46
ERAP1 Q9NZ08 1/20 0.46
CTSL P07711 1/20 0.46
APP P05067 1/20 0.45
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
ATM Q13315 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21684844 0.91 CTSK (0.56) CTSKCTSBKLK5SYKCTSS
SCHEMBL6279109 0.91 CTSK (0.56) CTSKCTSBKLK5SYKCTSS
SCHEMBL8141342 0.91 CTSK (0.56) CTSKCTSBKLK5SYKCTSS
SCHEMBL12873000 0.90 KLK5 (0.57) CTSKCTSBKLK5SYKCTSS
SCHEMBL12214464 0.90 KLK5 (0.57) CTSKCTSBKLK5SYKCTSS
SCHEMBL6388701 0.90 KLK5 (0.57) CTSKCTSBKLK5SYKCTSS
SCHEMBL24049752 0.88 CTSD (0.53) CTSKCTSBKLK5SYKCTSS
SCHEMBL7697656 0.86 CTSS (0.60) CTSKCTSBKLK5CTSSCTSL
SCHEMBL24049786 0.85 CTSK (0.71) CTSKCTSBCTSSCTSLPSEN1
SCHEMBL26269169 0.85 CTSK (0.71) CTSKCTSBCTSSCTSLPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363119-A1 PROTEASOME INHIBITORS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2021-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363119-A1 PROTEASOME INHIBITORS TP53, CDKN1A, PSME1 CTSK 646/4885CTSB 975/4885KLK5 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.